))
AI: The New Pipeline for Targeted Drug Discovery
Manage episode 329778875 series 3348048
Content provided by IEEE Standards Association (IEEE SA). All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by IEEE Standards Association (IEEE SA) or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
RNA splicing is at the forefront of providing insights into diseases that are linked back to RNA errors. Dr. Maria Luisa Pineda, CEO & Co-Founder at Envisagenics, explains how AI, HPC (high-performance computing), and genetic data can provide the insights needed for targeted drug discovery in oncology and other genetic conditions faster and more accurately than ever.
42 episodes
Share
